{"id":188,"date":"2026-08-01T05:15:38","date_gmt":"2026-08-01T05:15:38","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dsos-acquiring-dental-practices-atlanta\/"},"modified":"2026-08-01T05:15:38","modified_gmt":"2026-08-01T05:15:38","slug":"dsos-acquiring-dental-practices-atlanta","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dsos-acquiring-dental-practices-atlanta\/","title":{"rendered":"Which DSOs Are Acquiring Dental Practices in Atlanta?"},"content":{"rendered":"<h2>Key Takeaways for Atlanta Dentists<\/h2>\n<ul>\n<li>\n<p>Atlanta\u2019s dental market remains a seller\u2019s window in 2026, with multiple buyer types competing for a limited supply of high-quality practices.<\/p>\n<\/li>\n<li>\n<p>Buyer categories such as national DSOs, regional roll-ups, independent partnerships, platform private equity, and joint-venture DSOs can offer different valuations, deal terms, and post-close experiences.<\/p>\n<\/li>\n<li>\n<p>Reviewing a buyer\u2019s track record, capitalization, support systems, and earnout terms can be some of the main factors in protecting your outcome; McLerran maintains an active blacklist of problematic buyers.<\/p>\n<\/li>\n<li>\n<p>Valuations for premier practices stay near historically strong levels, influenced by practice size, associate depth, commercial payer mix, specialty services, and hygiene retention above 75%.<\/p>\n<\/li>\n<li>\n<p>McLerran Atlanta, led by Matt Sutton, reports an 85\u201390% transaction rate and valuations about 30% higher than many DIY sales; <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">schedule a free, confidential discovery call with McLerran &amp; Associates<\/a> to position your practice for a stronger result.<\/p>\n<\/li>\n<\/ul>\n<h2>Buyer Categories Actively Acquiring in Atlanta<\/h2>\n<p>Atlanta practice owners benefit from understanding the categories of buyers active in the market, because each category can bring a different valuation range, deal structure, and post-close experience. The table below maps the landscape as of 2026.<\/p>\n<table style=\"min-width: 150px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Buyer Category<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Geographic Focus<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Typical Practice Size<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Valuation Basis<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Cash at Close<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Post-Close Autonomy<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>National Platform Dental Service Organization<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Multi-state or national<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Larger practices<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Can reach 9\u201310x normalized EBITDA, and top platforms 11x+<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>60\u201380%<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Standardized protocols, centralized admin<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Regional Roll-Up<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Single state or metro area<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Solo to small group practices<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/www.thesorso.com\/answers\/dental-practice-ebitda-multiple\">9x\u201311x EBITDA for multi-location regional groups (and 5x\u20138x for single-location or add-on acquisitions)<\/a><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>60\u201380%<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Higher autonomy, lighter integration<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Independent Dental Service Organization Partnership<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Regional or national<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>High-producing practices<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>8x\u201311x on partial equity sold<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Independent buyers offer 100% cash at closing, while typical DSO offers pay 50\u201380% cash at close<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Founding dentist retains brand and majority control<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Platform Private Equity<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>National with regional activity<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Multi-location groups<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>7\u201310x EBITDA for platform deals<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>60\u201380% cash at close on platform deals<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically require 12\u201324 months of post-sale executive involvement<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Joint-Venture Dental Service Organization<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Regional or national<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Growth-stage practices<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Negotiated on stake sold<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Varies by structure<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Dentist retains majority ownership and clinical control<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>No specific firm names appear in this table by design. McLerran &amp; Associates vets buyers across all categories and has blacklisted those known for poor post-close environments, so Atlanta owners see only well-qualified, well-backed candidates.<\/em><\/p>\n<h2>Spotting Strong vs Weak Dental Service Organization Buyers<\/h2>\n<p>Not every buyer that approaches an Atlanta practice is a good partner. Dental service organization acquisition structures have shifted toward less upfront cash and more contingencies, and some buyers that entered the market when capital was cheap have since struggled operationally. Several criteria can help you evaluate a dental service organization buyer:<\/p>\n<ul>\n<li>\n<p><strong>Track record with prior sellers.<\/strong> Former affiliates who speak positively about the post-close experience can be a helpful signal. A buyer with unhappy sellers is a red flag regardless of headline price.<\/p>\n<\/li>\n<li>\n<p><strong>Capitalization and private equity backing.<\/strong> Rollover equity, which can represent 15\u201340% of a deal, is illiquid for 5\u20137 years and tied to the platform\u2019s financial health. An undercapitalized buyer puts that equity at higher risk.<\/p>\n<\/li>\n<li>\n<p><strong>Post-close support infrastructure.<\/strong> Genuine HR, billing, compliance, and recruiting support can reduce your workload. A buyer that mainly extracts margin while leaving the owner to manage operations alone can create strain.<\/p>\n<\/li>\n<li>\n<p><strong>Earnout structure fairness.<\/strong> Dental service organization-imposed changes to fee schedules, staffing, or scheduling systems can reduce a seller\u2019s ability to hit earnout targets, so the terms of any contingent payment can be critical to review carefully.<\/p>\n<\/li>\n<\/ul>\n<p>McLerran Atlanta, led by Matt Sutton, maintains an active blacklist of buyers whose post-close environments have harmed prior sellers. Those buyers never reach the table in a McLerran process.<\/p>\n<h2>Atlanta Dental Practice Valuations in 2026<\/h2>\n<p>Valuations in 2026 sit near historically strong levels for premier practices, although the market has moderated from the peak years of 2021\u20132023. Headline EBITDA multiples remain solid for premier practices, with typical ranges varying by practice size and quality.<\/p>\n<p>Several factors can move a valuation meaningfully within that range:<\/p>\n<ul>\n<li>\n<p>Practice size and EBITDA level, because larger, more profitable practices generally command higher multiples<\/p>\n<\/li>\n<li>\n<p>Associate production depth, since revenue that transfers cleanly after the owner departs is more valuable to buyers<\/p>\n<\/li>\n<li>\n<p>Commercial payer mix, where a mix above 50% commercial insurance tends to support premium valuations<\/p>\n<\/li>\n<li>\n<p>Specialty services, because orthodontics, oral surgery, and pediatric dentistry can attract meaningfully higher multiples than general dentistry alone<\/p>\n<\/li>\n<li>\n<p>Hygiene patient retention above 75%, which signals durable, recurring revenue<\/p>\n<\/li>\n<li>\n<p>Facility quality, lease terms, and growth capacity<\/p>\n<\/li>\n<\/ul>\n<p>McLerran\u2019s CPA-led EBITDA analysis reviews every discretionary, personal, and non-recurring expense to arrive at true profitability. This diligence-grade work can hold up when buyers scrutinize it and can reduce the risk of deals being re-traded downward.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<h2>Recent Dental Service Organization Activity in Metro Atlanta<\/h2>\n<p>Dental care recorded 161 deals in 2024, the highest volume of any healthcare category, with roughly 120+ PE add-on acquisitions, and the Southeast, including metro Atlanta, represents one of the more actively pursued regions. Several Southeast-focused platforms have documented operations and acquisition activity in Georgia, and national platforms with multi-state footprints continue to target profitable Atlanta-area practices.<\/p>\n<p>A recent industry survey found that 69% of dental service organizations expect a moderate or high increase in 2026 acquisition activity, while 78% anticipate recapitalization within 12 to 36 months, dynamics that can create negotiating leverage for well-positioned sellers. At the same time, these buyers face a reduced supply of premium practices, creating a high-demand, low-supply environment with increased buyer scrutiny on financials and performance projections.<\/p>\n<p>The practical implication for Atlanta owners is that qualified, well-presented practices can attract multiple competitive offers when they go to market through a structured process that reaches the full buyer universe.<\/p>\n<h2>Comparing Private-Buyer and DSO Paths for Atlanta Owners<\/h2>\n<p>McLerran &amp; Associates is one of the few dental-specific advisors that works both transition paths in roughly equal measure, with approximately 50% doctor-to-doctor sales and 50% dental service organization affiliations. That balance can make a genuine side-by-side comparison possible.<\/p>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Dimension<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Private Buyer (Doctor-to-Doctor)<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Dental Service Organization \/ Private Equity Affiliation<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Best-fit practice size<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically $1M\u2013$1.5M revenue<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically $1.5M+ revenue, largest practices $3M+<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Headline valuation<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Percentage of revenue or net cash flow multiple<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Dental service organization offers can be higher for larger, more profitable practices<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Cash at close<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically higher percentage, often near 100%<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>60\u201385%+ of total consideration, with the remainder in equity and earnout<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Post-sale work requirement<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Approximately 4\u20138 week work-back, then exit<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>3\u20135 year employment commitment typical<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Equity upside<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>None after sale<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Rollover equity offers potential \u201csecond bite\u201d at dental service organization recapitalization<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Closing timeline<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>60\u2013120 days<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>3\u20136 months<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Legacy and staff protection<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Buyer is a fellow dentist, so cultural continuity is often strong<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Varies by buyer, so vetting and fit assessment can be critical<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Owners in the $1.5M\u2013$3M revenue range, what McLerran calls the \u201cVenn diagram middle,\u201d can realistically pursue either path. A side-by-side valuation quantifies the real after-tax outcome on each path before any commitment is made.<\/p>\n<h2>Decision Steps: Valuation, Deal Terms, and Continuity<\/h2>\n<p>A structured decision process can help Atlanta owners move from uncertainty to a more confident plan. McLerran walks clients through the following steps:<\/p>\n<ol>\n<li>\n<p><strong>Establish diligence-grade EBITDA.<\/strong> A CPA-led analysis unpacks every add-back, such as owner compensation, personal expenses, and one-time costs, to arrive at true, normalized profitability. This number controls the narrative in every buyer conversation that follows.<\/p>\n<\/li>\n<li>\n<p><strong>Model both paths side by side.<\/strong> With that EBITDA baseline established, the next step is to use it as the foundation for forecasting. McLerran forecasts private-buyer and DSO outcomes across 3-, 5-, 7-, and 10-year horizons, including conservative recapitalization assumptions, so the owner sees real after-tax proceeds rather than only a headline number.<\/p>\n<\/li>\n<li>\n<p><strong>Understand deal structure components.<\/strong> A DSO deal typically involves three elements: cash at close (the guaranteed portion), rollover equity (a stake in the DSO\u2019s parent company, commonly illiquid for 5\u20137 years), and an earnout (contingent payments tied to post-close performance over 12\u201336 months). Each element carries different risk and tax treatment, and much of a DSO deal may qualify for long-term capital gains rates rather than ordinary income.<\/p>\n<\/li>\n<li>\n<p><strong>Evaluate post-close obligations.<\/strong> Employment agreement length, clinical autonomy, compensation structure, and earnout metrics all affect the owner\u2019s day-to-day life after closing. Non-punitive earnout terms, such as pro-rata provisions for near-misses on targets, can be worth negotiating explicitly.<\/p>\n<\/li>\n<li>\n<p><strong>Protect staff and patients.<\/strong> The right buyer is not always the highest bidder. Fit assessment, including a buyer\u2019s support model, culture, and track record with prior sellers, can be as important as the financial terms.<\/p>\n<\/li>\n<\/ol>\n<h2>How McLerran Atlanta Drives Competition for Sellers<\/h2>\n<p>McLerran &amp; Associates reports a transaction rate of roughly 85\u201390% among its clients, compared to an industry norm closer to 35\u201340% and a do-it-yourself close rate that can be as low as 15\u201320%. That gap reflects a structured process rather than chance.<\/p>\n<p>The McLerran Atlanta process, led by Matt Sutton, generates competitive bids from a vetted pool of well-qualified buyers. The process narrows from that initial field to in-person meetings with the top one to three finalists, with McLerran managing competition throughout to prevent any single buyer from anchoring the price.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<p>Across roughly 2,000 successful practice sales and approximately $2 billion in closed transaction volume, the firm has found that clients typically achieve valuations around 30% higher than owners who sell on their own. That lift comes from competitive tension, which a single-buyer negotiation structurally cannot produce.<\/p>\n<p>McLerran is sell-side only and never represents the buyer. Its incentives stay aligned with the Atlanta practice owner across every stage of the transaction.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Schedule a free, confidential discovery call with McLerran &amp; Associates<\/a> to learn how the Atlanta office can run this process for your practice.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>Which types of dental service organizations are most active in acquiring Atlanta dental practices right now?<\/h3>\n<p>Atlanta attracts buyer interest across several categories, including national platform dental service organizations with multi-state footprints, Southeast-focused regional consolidators, independent dental service organization partnerships that allow the founding dentist to retain the practice brand, and private equity-backed platform buyers targeting larger multi-location groups. The category that is most relevant to a specific practice can depend on its size, EBITDA, specialty mix, and the owner\u2019s post-close goals. A structured sell-side process reaches all relevant buyer categories at the same time rather than limiting the owner to whichever buyer happened to call first.<\/p>\n<h3>What is a realistic valuation range for an Atlanta dental practice in 2026?<\/h3>\n<p>Valuation ranges in 2026 vary meaningfully by practice size, profitability, specialty, and buyer type. Solo general practices at smaller EBITDA levels tend to attract lower multiples, while multi-location groups and specialty practices, particularly oral surgery, orthodontics, and pediatric dentistry, can command substantially higher ranges. A practice\u2019s specific multiple is usually determined by its individual financials and the competitive tension created among buyers rather than by a fixed table. A diligence-grade EBITDA analysis, completed before going to market, can be one of the more reliable ways to establish a defensible number that is less likely to be re-traded in due diligence.<\/p>\n<h3>How do I evaluate whether a dental service organization is a good long-term partner for my Atlanta practice?<\/h3>\n<p>Evaluating a dental service organization as a partner involves looking beyond the headline offer. Key considerations include the buyer\u2019s financial backing and whether its parent private equity firm has a track record of successful exits, the experiences of dentists who have already affiliated with that buyer, the specifics of the post-close employment agreement including autonomy over treatment planning and staffing, and the structure of any rollover equity, which can represent a significant portion of total deal value and is typically illiquid for several years. McLerran maintains an active blacklist of buyers whose post-close environments have been problematic, and those buyers are excluded from the process before any Atlanta owner sees an offer.<\/p>\n<h3>Should I sell to a private buyer or affiliate with a DSO?<\/h3>\n<p>The right path can depend on practice size, profitability, and what the owner wants from the transition. Practices in the $1M\u2013$1.5M revenue range often fit a doctor-to-doctor sale well, with a cleaner exit and a shorter post-sale work commitment. Practices above $1.5M in revenue, and especially those above $3M, tend to attract stronger DSO interest and higher headline valuations, although a meaningful portion of that value may be deferred as equity or earnout. Owners in the middle range can genuinely pursue either path, and a side-by-side valuation that quantifies the real after-tax outcome on each can be one of the most reliable ways to choose with fuller information rather than guesswork.<\/p>\n<h3>Is 2026 a good time to sell a dental practice in Atlanta?<\/h3>\n<p>Buyer demand for premier Atlanta-area practices remains strong, and valuations sit near historically high levels for well-run, well-presented practices. At the same time, the market has become more selective, with buyers scrutinizing financials more carefully and a wider spread between the best offers and middle-tier offers. Practices that go to market with a diligence-grade valuation and a structured competitive process can be better positioned to capture the top of that range. Owners who are not yet ready can receive a complimentary valuation update a year later, and McLerran does not push clients into deals before they feel prepared.<\/p>\n<h2>Conclusion and Next Steps for Atlanta Practice Owners<\/h2>\n<p>Atlanta\u2019s dental M&amp;A market in 2026 can offer real opportunity for owners of premier practices who approach it with the right preparation, representation, and process. Understanding buyer categories, valuation drivers, and deal structure mechanics can provide a foundation. Creating genuine competition among vetted buyers is often what converts that knowledge into a stronger outcome.<\/p>\n<p>McLerran &amp; Associates\u2019 Atlanta office, led by Matt Sutton, brings the firm\u2019s full platform, including diligence-grade EBITDA analysis, a vetted national buyer pool, an active blacklist, and a structured competitive bid process, to Atlanta practice owners weighing a 2026 transition. The firm\u2019s experience across roughly 2,000 successful sales and approximately $2 billion in closed transaction volume supports a process focused on execution rather than simple listing.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Schedule a free, confidential discovery call with McLerran &amp; Associates<\/a> to discuss your practice, your goals, and what a competitive process could mean for your outcome. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com\/contact-us.<\/p>\n<p>Owners who are not ready to sell yet can still get educated. Join the McLerran M&amp;A Summit on October 29\u201330, 2026, a dental-only event built for owners who have not decided yet. Attendees receive 4 CE credits and a complimentary practice valuation (a $2,500 value), which can be a low-pressure way to prepare for one of the largest financial decisions of your career.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>See which DSOs are buying Atlanta dental practices in 2026. McLerran helps you compare buyers, protect your valuation, and close with confidence.<\/p>\n","protected":false},"author":1,"featured_media":187,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-188","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=188"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/188\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/187"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}